Top Stories
-
A cost-effectiveness study led by a Columbia medical student suggests liquid biopsies are not yet up to the task of screening for colon cancer.
Topic
-
A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Topic
-
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Topic
-
Columbia Nursing’s dean, Lorraine Frazier, shares the lessons she learned from her breast cancer journey.
Topic
Latest News
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- January 27, 2022
Active surveillance has emerged as a safe option for some thyroid cancers, illustrating that less can be more in thyroid cancer management.
- January 25, 2022
Columbia cancer researchers are developing virtual reality technology to visualize and explore cancer tumors and gain new insights.
- January 24, 2022
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
- January 19, 2022
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Topic
- January 11, 2022
In the face of daunting disparities in health care, the medical community can take small steps that make a difference, a Columbia orthopedic surgeon writes.
Topic
- December 23, 2021
The National Cancer Act, signed into law Dec. 23, 1971, funded the expansion of cancer research and care at Columbia. Today, with plans for a new clinical building, the future looks bright.
Topic
- December 17, 2021
Innovation and discovery are at the heart of Herbert Irving Comprehensive Cancer Center's mission to reduce the burden of cancer. Learn more in the HICCC's 2021 annual report.
- December 17, 2021
The new center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.
- December 6, 2021
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
Topic
